Published in Neurology on August 05, 2008
Efficacy and Safety of DHEA for Myotonic Dystrophy | NCT00167609
Therapeutics development in myotonic dystrophy type 1. Muscle Nerve (2011) 1.07
Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction. Dis Model Mech (2015) 0.80
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis (1991) 4.74
Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98
Half the families of intensive care unit patients experience inadequate communication with physicians. Crit Care Med (2000) 3.78
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med (2009) 3.32
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature (2000) 2.85
Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med (1993) 2.84
Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med (2007) 2.65
Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol (1999) 2.63
[Recording expulsive forces during childbirth using intercostal muscle electromyogram: a pilot study]. Gynecol Obstet Fertil (2005) 2.62
A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med (1992) 2.51
Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology (2007) 2.47
French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest (1999) 2.34
Multifocal motor neuropathy with and without conduction block: a single entity? Neurology (2006) 2.18
Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol (1997) 2.16
Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis (1996) 2.14
Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J (2005) 2.04
Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat? Neurology (2011) 2.04
Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol (1999) 2.03
Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology (2010) 2.01
Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology (2002) 1.96
Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med (2001) 1.94
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology (2005) 1.90
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol (2003) 1.86
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol (2008) 1.81
Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation (1999) 1.78
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood (1996) 1.78
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res (1999) 1.74
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood (2001) 1.74
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73
Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve (2004) 1.73
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat (2002) 1.71
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett (1997) 1.70
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med (1993) 1.68
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients. Leukemia (2004) 1.63
Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med (1993) 1.62
Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med (1999) 1.62
High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology (2010) 1.61
Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology (2006) 1.61
[Disulfiram (Esperal) toxicity. Apropos of 3 original cases]. Rev Med Interne (1995) 1.60
Hydroxyapatite-coated versus grit-blasted femoral stems. a prospective, randomised study using EBRA-FCA. J Bone Joint Surg Br (2001) 1.60
High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol (2000) 1.58
Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest (1998) 1.58
Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol (1996) 1.58
Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics (2009) 1.58
Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet (1998) 1.57
Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med (1997) 1.57
Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood (1993) 1.55
Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53
World Health Organization grade 'a' motility and zona-binding test accurately predict IVF outcome for mild male factor and unexplained infertilities. Hum Reprod (2005) 1.52
A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol (2002) 1.52
Meeting the needs of intensive care unit patient families: a multicenter study. Am J Respir Crit Care Med (2001) 1.52
The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis (2002) 1.51
Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis (1996) 1.51
[Hereditary neuropathy with liability to pressure palsy presenting with an acute inflammatory demyelinating polyneuropathy]. Rev Neurol (Paris) (2004) 1.50
Intravenous immunoglobulin treatment in multifocal motor neuropathy. Lancet (1992) 1.50
MSH4 acts in conjunction with MLH1 during mammalian meiosis. FASEB J (2000) 1.50
Sniff nasal inspiratory pressure: what is the optimal number of sniffs? Eur Respir J (2006) 1.48
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood (1998) 1.48
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation (1994) 1.47
31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology (1992) 1.47
[Pathophysiology and treatment of fatigue in multiple sclerosis]. Rev Neurol (Paris) (2006) 1.47
Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol (1997) 1.46
Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology (1991) 1.46
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease? J Neurol (2001) 1.45
Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol (2001) 1.44
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia (2005) 1.44
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia (1998) 1.42
Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis. Eur Neurol (2008) 1.42
Distinct muscle imaging patterns in myofibrillar myopathies. Neurology (2008) 1.41
Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome. Neurology (2005) 1.41
Ventilatory assistance in patients with Duchenne muscular dystrophy. Eur Respir J (2006) 1.41
Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level. Br J Haematol (1997) 1.40
B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood (1991) 1.40